login
login

Europe Daily Bulletin No. 8123

7 January 2002
Contents Publication in full By article 32 / 34
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

Germany's SCHERING has acquired the remaining 40% of the French laboratory CIS BIO INTERNATIONAL for an undisclosed sum from AREVA (nuclear products) following SCHERING's acquisition in 2000 of 60% of the company which develops and markets nuclear medical diagnostic products and products for the treatment of cancer.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION